The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design

EuroIntervention 2007;3:371-380 - DOI10.4244/EIJV3I3A67.

1. Isala Klinieken, Dept of Cardiology, Zwolle, The Netherlands; 2. Kerckhoff-Klinik GmbH, Bad Nauheim, Germany; 3. Merck & Co., Inc., Whitehouse Station, NJ, USA; 4. Merck Research Laboratories, Rahway, NJ, USA; 5. St Antonius Ziekenhuis, Dept of Car

Aims: Delays in initiation of treatment because of transportation of high-risk patients with ST-elevation myocardial infarction (STEMI) are associated with worse clinical outcome. Glycoprot

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents